Search
for
Sort by
Research 211–240 of 1000+
- Melasma and Endocrine Disorders
- Steroid sulfatase inhibitors
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Life Sciences Discovery and Technology Highlights
- Foreword
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Wnt signaling: the good and the bad
- Treatment options for alopecia: an update, looking to the future
- Topical Finasteride Therapy in Hirsutism
- Relative search popularity of five advanced prostate cancer medications using Google Trends
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Hair, Hormones, and High-Risk Prostate Cancer
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Inhibitory Effects of Pueraria mirifica Aqueous Extracts on 5α-reductase and Prostate Histomorphometry in Testosterone-induced Benign Prostatic Hyperplasia Sprague Dawley Rats
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Relative binding affinity of novel steroids to androgen receptors in hamster prostate
- Prostate Carcinoma, what would be the best to do ?
- Alopecia Areata Developing in Non-Insulin Dependent Diabetes Mellitus Type-2, an Autoimmune Disease
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- Redefining hormone resistance in prostate cancer
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Male pattern baldness and the risk of prostate cancer
- Male pattern baldness and its association with coronary heart disease: a meta-analysis
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Skin diseases in consequence of endocrine alterations